Evidence map›Paper›PMID 28223349›Full record

ArticleMolecular & cellular proteomics : MCP2017

Identification of Antibody Targets for Tuberculosis Serology using High-Density Nucleic Acid Programmable Protein Arrays.

Lusheng Song, Garrick Wallstrom, Xiaobo Yu, Marika Hopper, Jennifer Van Duine, Jason Steel, Jin Park, Peter Wiktor, Peter Kahn, Al Brunner and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Discovery of a Unique Set of Dog-SeroreactiveJournal of fungi (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Comparative Microbiomics Analysis of Antimicrobial Antibody Response between Patients with Lung Cancer and Control Subjects with Benign Pulmonary Nodules.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  11. Article
  12. Review
  13. Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
  14. Review
  15. Review
  16. Article
  17. Developments and Applications of Functional Protein Microarrays.Molecular & cellular proteomics : MCP · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Lusheng SongFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
Garrick WallstromFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
Xiaobo Yu§State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Radiation Medicine, Beijing, 102206, China.
Marika HopperFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
Jennifer Van DuineFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
Jason SteelFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
Jin ParkFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
Peter WiktorFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
Peter Kahn¶Engineering Arts LLC, Tempe, Arizona 85287.
Al Brunner¶Engineering Arts LLC, Tempe, Arizona 85287.
Douglas Wilson‖Department of Internal Medicine, Edendale Hospital, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Elizabeth R Jenny-Avital**Departments of Medicine and.
Ji QiuFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
Joshua LabaerFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287.
D Mitchell MageeFrom the ‡The Virginia G Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona, 85287; jacqueline.achkar@einstein.yu.edu mitch.magee@asu.edu.
Jacqueline M Achkar**Departments of Medicine and jacqueline.achkar@einstein.yu.edu mitch.magee@asu.edu.
Arizona State University · USEngineering Arts (United States) · USAlbert Einstein College of Medicine · USBeijing Proteome Research Center · CNEdendale Hospital · ZA

Funding

Host biomarkers for M. tuberculosis infection activity in HIV-infected personsR01AI117927 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ACHKAR, JACQUELINE MICHELE · 2016 to 2020
$3.6M
Piezoelectric Pipetting for High Density Nucleic Acid Programmable Protein ArraysR42GM106704 · NIGMS · ENGINEERING ARTS, LLC · PI WIKTOR, PETER J. · 2012 to 2014
$1.8M
Antibody Biomarkers for Early Detection of TuberculosisR01AI096213 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MAGEE, D MITCHELL · 2011 to 2012
$1.0M
Novel serological biomarker for rapid tuberculosis diagnosisR21AI105684 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ACHKAR, JACQUELINE MICHELE · 2013 to 2014
$444k
NIAID NIH HHS R01 AI096213NIAID NIH HHS R01 AI117927NIAID NIH HHS R21 AI105684NIGMS NIH HHS R42 GM106704
6 · The paper itself

Abstract

Better and more diverse biomarkers for the development of simple point-of-care tests for active tuberculosis (TB), a clinically heterogeneous disease, are urgently needed. We generated a proteomic

Indexed as

AdultAgedBacterial ProteinsBiomarkersCoinfectionFemaleHIV InfectionsHumansMaleMiddle AgedMycobacterium tuberculosisProtein Array AnalysisProteomicsROC CurveSerum Bactericidal Antibody AssaySouth AfricaBacterial ProteinsBiomarkers

Identifiers

PMID28223349
PMCPMC5393403
OpenAlexW2590455876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.